RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1
Christopher P. Mill(The University of Texas MD Anderson Cancer Center), Kapil N. Bhalla(University of South Florida)
Cited by 98
Related Papers
Inhibition of Histone Deacetylase 6 Acetylates and Disrupts the Chaperone Function of Heat Shock Protein 90
|Journal of Biological Chemistry|2005|749
Clinical experience with the <scp>BCL</scp>2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
|American Journal of Hematology|2017|437
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics
|Nature Communications|2020|383